Evidence map›Paper›PMID 30251109›Full record

Trial reportHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2018

Effects on Cardiovascular Risk Scores and Vascular Age After Aerobic Exercise and Nutritional Intervention in Sedentary and Overweight/Obese Adults with Primary Hypertension: The EXERDIET-HTA Randomized Trial Study.

Ilargi Gorostegi-Anduaga, Sara Maldonado-Martín, Aitor MartinezAguirre-Betolaza, Pablo Corres, Estíbaliz Romaratezabala, Anna C Whittaker, Silvia Francisco-Terreros, Javier Pérez-Asenjo

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ilargi Gorostegi-AnduagaLaboratory of Performance Analysis in Sport, Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Science Section, University of the Basque Country (UPV/EHU), Portal de Lasarte 71, 01007, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.ORCID http://orcid.org/0000-0002-1571-8408
Sara Maldonado-MartínLaboratory of Performance Analysis in Sport, Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Science Section, University of the Basque Country (UPV/EHU), Portal de Lasarte 71, 01007, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain. sara.maldonado@ehu.eus.ORCID http://orcid.org/0000-0002-2622-5385
Aitor MartinezAguirre-BetolazaLaboratory of Performance Analysis in Sport, Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Science Section, University of the Basque Country (UPV/EHU), Portal de Lasarte 71, 01007, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.ORCID http://orcid.org/0000-0002-6563-4325
Pablo CorresLaboratory of Performance Analysis in Sport, Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Science Section, University of the Basque Country (UPV/EHU), Portal de Lasarte 71, 01007, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.ORCID http://orcid.org/0000-0002-2363-2962
Estíbaliz RomaratezabalaLaboratory of Performance Analysis in Sport, Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Science Section, University of the Basque Country (UPV/EHU), Portal de Lasarte 71, 01007, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.
Anna C WhittakerSchool of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Silvia Francisco-TerrerosClinical Trials Unit, Health and Quality of Life Area, TECNALIA, Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.
Javier Pérez-AsenjoCardiology Unit, Igualatorio Médico Quirúrgico (IMQ-Amárica), Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain.
University of the Basque Country · ESUniversity of Birmingham · GB

Funding

THE BASQUE GOVERNMENT PREDOCTORAL GRANT 2015THE BASQUE GOVERNMENT PREDOCTORAL GRANT 2016THE BASQUE GOVERNMENT PREDOCTORAL GRANT 2017UNIVERSITY OF THE BASQUE COUNTRY (UPV/EHU) EHU14/08UNIVERSITY OF THE BASQUE COUNTRY (UPV/EHU) PPGA18/15
6 · The paper itself

Abstract

introductionThe EXERDIET-HTA study was a multi-arm parallel, a randomized, single-blind controlled experimental trial comparing the effects of 16 weeks of different aerobic exercise programs two days per week, and dietary intervention in a hypertensive, overweight/obese and non-physically active population.

aimTo evaluate the influence of diet and aerobic exercise program intervention on cardiovascular risk (CVR) factors and predicted CVR and vascular age (VA) profiles in overweight/obese people with primary hypertension (HTN), and to analyze the potential sex differences in the ability to predict VA and CVR via different methods.

methodsThe CVR and VA determined (n = 167, 53.7 ± 7.8 years) using the Framingham Risk Score (FRS) and the new equation for the prediction of 10-year atherosclerotic cardiovascular disease (ASCVD) risk, before and after the 16-week intervention period (different aerobic exercise programs + hypocaloric diet). The sex-specific risk factors considered were age, high-density lipoprotein cholesterol (HDL-C), total cholesterol, systolic blood pressure (SBP), diabetes mellitus (DM) and smoking status.

resultsFrom baseline to follow-up, participants reduced (p ≤ 0.001) FRS-CVR score and VA, and SBP. Total cholesterol decreased significantly, but specifically in men (p ≤ 0.001), and antihypertensive medication (%) in women (p = 0.047). No significant differences over time were observed for HDL-C, smoking, DM overall for either sex. For ASCVD-CVR there was no overall change or for either sex. After the intervention, women had a lower CVR score than men (p ≤ 0.001), irrespective of the calculation method.

conclusionsThe improvement in CVR factors after 16-week lifestyle changes reduced the risk of suffering a cardiovascular event in overweight/obese adults with HTN through the FRS estimation tool, but not with the ASCVD score. The risk score algorithms could underestimate CVR in women. In contrast, VA could be a useful and easier tool in the management of individuals with CVR factors.

Indexed as

Blood PressureCaloric RestrictionRisk Reduction BehaviorSedentary BehaviorAntihypertensive AgentsBiomarkersCholesterolCholesterol, HDLCombined Modality TherapyDiabetes MellitusExercise TherapyFemaleHumansHypertensionMaleMiddle AgedAntihypertensive AgentsBiomarkersCholesterolCholesterol, HDLCardiovascular risk scoreGenderLifestyle interventionObesityOverweightSystolic blood pressureVascular age

Identifiers

PMID30251109
OpenAlexW2893420795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.